Social Media Use of Psoriasis Vulgaris Patients: Multicenter, Survey Work

Psoriasis Vulgaris Clinical Trial

Official title:

Social Media Use of Psoriasis Vulgaris Patients: Multicenter, Survey Work

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04207242
• Other study ID #: IstanbulMU5
• Status: Completed
• Start date: January 1, 2020
• Est. completion date: July 1, 2020

Study information

• Verified date: February 2021
• Source: Istanbul Medeniyet University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Psoriasis Vulgaris is a chronic, recurrent, inflammatory and hyperproliferative skin disease. Joint involvement is common along with skin involvement. However, metabolic diseases, such as cardiovascular diseases can be accompanied by many systemic diseases, chronic and repetitive due to the quality of life and psychological status of patients can affect. For this reason, patients carry out various research on their diseases on social media and follow programs on these issues in other media such as television and radio. However, there is no study on how much patients are interested in these publications, how much they trust them, and how they reach and organize information via social media. The aim of the study will be to clarify how and how patients with Psoriasis Vulgaris use social media to obtain information about the diagnosis and treatment of their disease, the interaction of patient groups with each other, and how often social media is used, especially in which group of patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1520
• Est. completion date: July 1, 2020
• Est. primary completion date: January 1, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• Psoriasis vulgaris patients

Exclusion Criteria:

• patients that don't want to answer questions

Related Conditions & MeSH terms

• Psoriasis
• Psoriasis Vulgaris

Locations

Country	Name	City	State
Turkey	Melek Aslan Kayiran	Istanbul

Sponsors (1)

Lead Sponsor	Collaborator
Istanbul Medeniyet University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Social media use of psoriasis vulgaris patients, a questionnaire will be asked the patients and try to learn how they use social media for getting information about their disease.		July 2020